LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, google, scholar, cas, article, cancer, peptide, cells, peptides, herneu, cell, immunol, patients, class, tumor, humphreys, baxevanis, human, res, hybrid, papamichail, mhc, vaccine, epitope, immunotherapy, sotiriadou, gritzapis, immunity, responses, tumors, kallinteris, ctl, breast, immunother, autologous, helper, epitopes, lymphocytes, perez, specific, access, privacy, cookies, content, iikeyherneu, hofe, invariant, chain, iikey, dendritic,

Topics {✒️}

her2/neu-derived peptide epitopes month download article/chapter mhc class ii peptide-based vaccines hybrid peptide-specific cd4+ ii-key-enhancing effects human leukocyte antigen-dr1 melanoma-specific cytolytic cd8+ human tumor-reactive cd4+ lopez-diaz de cerio ny-eso-1 epitopes presented human tumor-specific ctls ifn-γ elispot assays ny-eso-1-expressing melanoma vitro-induced specific cd4 major “post-licensing-role g89-activated cells regulate cytotoxic-t-cell responses related subjects ii-key peptide mhc class human histocompatibility antigen 2/neu-derived peptide 884-99 high-affinity p53a2 article cancer immunology peptide her2 full article pdf antigen-specific cd4+ tumor-specific cd4+ tumor antigen-specific hybrid peptide linking homologous ii-key/ peptide-specific ctl effective immunological responses cd4+ t-helper t-killer cell helper peptide g89 tumor-derived helper patient-derived cd4+ privacy choices/manage cookies human primary breast eric von hofe & robert tumor cell vaccine quantify antigen-specific human tumor antigens ii-key segment class ii peptide-specific cytotoxic knutson kl tumor specific cytolysis

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors
         description:We have demonstrated that coupling an immunoregulatory segment of the MHC class II-associated invariant chain (Ii), the Ii-Key peptide, to a promiscuous MHC class II epitope significantly enhances its presentation to CD4+ T cells. Here, a series of homologous Ii-Key/HER-2/neu(776-90) hybrid peptides, varying systematically in the length of the epitope(s)-containing segment, are significantly more potent than the native peptide in assays using T cells from patients with various types of tumors overexpressing HER-2/neu. In particular, priming normal donor and patient PBMCs with Ii-Key hybrid peptides enhances recognition of the native peptide either pulsed onto autologous dendritic cells (DCs) or naturally presented by IFN-γ-treated autologous tumor cells. Moreover, patient-derived CD4+ T cells primed with the hybrid peptides provide a significantly stronger helper effect to autologous CD8+ T cells specific for the HER-2/neu(435-43) CTL epitope, as illustrated by either IFN-γ ELISPOT assays or specific autologous tumor cell lysis. Hybrid peptide-specific CD4+ T cells strongly enhanced the antitumor efficacy of HER-2/neu(435-43) peptide-specific CTL in the therapy of xenografted SCID mice inoculated with HER-2/neu overexpressing human tumor cell lines. Our data indicate that the promiscuously presented vaccine peptide HER-2/neu(776-90) is amenable to Ii-Key-enhancing effects and supports the therapeutic potential of vaccinating patients with HER-2/neu+ tumors with such Ii-Key/HER-2/neu(776-90) hybrid peptides.
         datePublished:2006-09-08T00:00:00Z
         dateModified:2006-09-08T00:00:00Z
         pageStart:601
         pageEnd:613
         sameAs:https://doi.org/10.1007/s00262-006-0213-z
         keywords:
            Ii-Key hybrid peptides
            HER-2/neu peptides
            Cancer vaccines
            T helper cells
            CTL
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig6_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:56
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nectaria N. Sotiriadou
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nikoletta L. Kallinteris
               affiliation:
                     name:Antigen Express Inc.
                     address:
                        name:Antigen Express Inc., Worcester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Angelos D. Gritzapis
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ioannis F. Voutsas
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Papamichail
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric von Hofe
               affiliation:
                     name:Antigen Express Inc.
                     address:
                        name:Antigen Express Inc., Worcester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert E. Humphreys
               affiliation:
                     name:Antigen Express Inc.
                     address:
                        name:Antigen Express Inc., Worcester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Theodoros Pavlis
               affiliation:
                     name:Surgical Clinic “Mitera-Hospital
                     address:
                        name:Surgical Clinic “Mitera-Hospital, Marousi, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sonia A. Perez
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Constantin N. Baxevanis
               affiliation:
                     name:Saint Savas Cancer Hospital
                     address:
                        name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors
      description:We have demonstrated that coupling an immunoregulatory segment of the MHC class II-associated invariant chain (Ii), the Ii-Key peptide, to a promiscuous MHC class II epitope significantly enhances its presentation to CD4+ T cells. Here, a series of homologous Ii-Key/HER-2/neu(776-90) hybrid peptides, varying systematically in the length of the epitope(s)-containing segment, are significantly more potent than the native peptide in assays using T cells from patients with various types of tumors overexpressing HER-2/neu. In particular, priming normal donor and patient PBMCs with Ii-Key hybrid peptides enhances recognition of the native peptide either pulsed onto autologous dendritic cells (DCs) or naturally presented by IFN-γ-treated autologous tumor cells. Moreover, patient-derived CD4+ T cells primed with the hybrid peptides provide a significantly stronger helper effect to autologous CD8+ T cells specific for the HER-2/neu(435-43) CTL epitope, as illustrated by either IFN-γ ELISPOT assays or specific autologous tumor cell lysis. Hybrid peptide-specific CD4+ T cells strongly enhanced the antitumor efficacy of HER-2/neu(435-43) peptide-specific CTL in the therapy of xenografted SCID mice inoculated with HER-2/neu overexpressing human tumor cell lines. Our data indicate that the promiscuously presented vaccine peptide HER-2/neu(776-90) is amenable to Ii-Key-enhancing effects and supports the therapeutic potential of vaccinating patients with HER-2/neu+ tumors with such Ii-Key/HER-2/neu(776-90) hybrid peptides.
      datePublished:2006-09-08T00:00:00Z
      dateModified:2006-09-08T00:00:00Z
      pageStart:601
      pageEnd:613
      sameAs:https://doi.org/10.1007/s00262-006-0213-z
      keywords:
         Ii-Key hybrid peptides
         HER-2/neu peptides
         Cancer vaccines
         T helper cells
         CTL
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0213-z/MediaObjects/262_2006_213_Fig6_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:56
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nectaria N. Sotiriadou
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nikoletta L. Kallinteris
            affiliation:
                  name:Antigen Express Inc.
                  address:
                     name:Antigen Express Inc., Worcester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Angelos D. Gritzapis
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ioannis F. Voutsas
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Papamichail
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric von Hofe
            affiliation:
                  name:Antigen Express Inc.
                  address:
                     name:Antigen Express Inc., Worcester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert E. Humphreys
            affiliation:
                  name:Antigen Express Inc.
                  address:
                     name:Antigen Express Inc., Worcester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Theodoros Pavlis
            affiliation:
                  name:Surgical Clinic “Mitera-Hospital
                  address:
                     name:Surgical Clinic “Mitera-Hospital, Marousi, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sonia A. Perez
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Constantin N. Baxevanis
            affiliation:
                  name:Saint Savas Cancer Hospital
                  address:
                     name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:56
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
      name:Antigen Express Inc.
      address:
         name:Antigen Express Inc., Worcester, USA
         type:PostalAddress
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
      name:Antigen Express Inc.
      address:
         name:Antigen Express Inc., Worcester, USA
         type:PostalAddress
      name:Antigen Express Inc.
      address:
         name:Antigen Express Inc., Worcester, USA
         type:PostalAddress
      name:Surgical Clinic “Mitera-Hospital
      address:
         name:Surgical Clinic “Mitera-Hospital, Marousi, Greece
         type:PostalAddress
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
      name:Saint Savas Cancer Hospital
      address:
         name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nectaria N. Sotiriadou
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Nikoletta L. Kallinteris
      affiliation:
            name:Antigen Express Inc.
            address:
               name:Antigen Express Inc., Worcester, USA
               type:PostalAddress
            type:Organization
      name:Angelos D. Gritzapis
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Ioannis F. Voutsas
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Michael Papamichail
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Eric von Hofe
      affiliation:
            name:Antigen Express Inc.
            address:
               name:Antigen Express Inc., Worcester, USA
               type:PostalAddress
            type:Organization
      name:Robert E. Humphreys
      affiliation:
            name:Antigen Express Inc.
            address:
               name:Antigen Express Inc., Worcester, USA
               type:PostalAddress
            type:Organization
      name:Theodoros Pavlis
      affiliation:
            name:Surgical Clinic “Mitera-Hospital
            address:
               name:Surgical Clinic “Mitera-Hospital, Marousi, Greece
               type:PostalAddress
            type:Organization
      name:Sonia A. Perez
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      name:Constantin N. Baxevanis
      affiliation:
            name:Saint Savas Cancer Hospital
            address:
               name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
      name:Antigen Express Inc., Worcester, USA
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
      name:Antigen Express Inc., Worcester, USA
      name:Antigen Express Inc., Worcester, USA
      name:Surgical Clinic “Mitera-Hospital, Marousi, Greece
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
      name:Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(177)

• How profitable is https://www.springernature.com/gp/authors?
• Explore the financials of https://link.springernature.com/home/
• How much does https://order.springer.com/public/cart make?
• Check the income stats for https://submission.nature.com/new-submission/262/3
• How much profit does https://www.springernature.com/gp/librarians/licensing/agc/journals generate?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9342425
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Biological%20activity%20and%20therapeutic%20potential%20of%20homologs%20of%20an%20Ii%20peptide%20which%20regulates%20antigenic%20peptide%20binding%20to%20cell%20surface%20MHC%20class%20II%20molecules&journal=Arzneimittelforschung&volume=47&pages=1069-1077&publication_year=1997&author=Adams%2CS&author=Albericio%2CF&author=Alsina%2CJ&author=Smith%2CER&author=Humphreys%2CRE generate?
• Learn about the earnings of https://doi.org/10.1002%2Feji.1830250632
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7614997 rake in every month?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Invariant%20chain%20peptides%20enhancing%20or%20inhibiting%20the%20presentation%20of%20antigenic%20peptides%20by%20major%20histocompatibility%20complex%20class%20II%20molecules&journal=Eur%20J%20Immunol&doi=10.1002%2Feji.1830250632&volume=25&pages=1693-1702&publication_year=1995&author=Adams%2CS&author=Humphreys%2CRE?
• Revenue of https://doi.org/10.1016%2Fj.coi.2004.01.012
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15023403?
• How much does http://scholar.google.com/scholar_lookup?&title=Current%20developments%20of%20immunotherapy%20in%20the%20clinic&journal=Curr%20Opin%20Immunol&doi=10.1016%2Fj.coi.2004.01.012&volume=16&pages=130-136&publication_year=2004&author=Antonia%2CS&author=Mule%2CJJ&author=Weber%2CJS pull in?
• Explore the financials of https://doi.org/10.1158%2F0008-5472.CAN-05-3793
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16488988 make?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Ex%20vivo%20detectable%20human%20CD8%20T-cell%20responses%20to%20cancer-testis%20antigens&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-3793&volume=66&pages=1912-1916&publication_year=2006&author=Baumgaertner%2CP&author=Rufer%2CN&author=Devevre%2CE&author=Derre%2CL&author=Rimoldi%2CD&author=Geldhof%2CC&author=Voelter%2CV&author=Lienard%2CD&author=Romero%2CP&author=Speiser%2CDE?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7917907's revenue stream
• See how much http://scholar.google.com/scholar_lookup?&title=Interleukin%201%20beta%20synergises%20with%20interleukin%202%20in%20the%20outgrowth%20of%20autologous%20tumour-reactive%20CD8%C2%A0%2B%C2%A0%20effectors&journal=Br%20J%20Cancer&volume=70&pages=625-630&publication_year=1994&author=Baxevanis%2CCN&author=Dedoussis%2CGV&author=Gritzapis%2CAD&author=Stathopoulos%2CGP&author=Papamichail%2CM makes per month
• How much revenue does https://doi.org/10.1002%2F1097-0142%2819940815%2974%3A4%3C1275%3A%3AAID-CNCR2820740416%3E3.0.CO%3B2-Q bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7914469 gross monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Tumor%20specific%20cytolysis%20by%20tumor%20infiltrating%20lymphocytes%20in%20breast%20cancer&journal=Cancer&doi=10.1002%2F1097-0142%2819940815%2974%3A4%3C1275%3A%3AAID-CNCR2820740416%3E3.0.CO%3B2-Q&volume=74&pages=1275-1282&publication_year=1994&author=Baxevanis%2CCN&author=Dedoussis%2CGV&author=Papadopoulos%2CNG&author=Missitzis%2CI&author=Stathopoulos%2CGP&author=Papamichail%2CM
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14685781's revenue stream
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Immunobiology%20of%20HER-2%2Fneu%20oncoprotein%20and%20its%20potential%20application%20in%20cancer%20immunotherapy&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-003-0475-7&volume=53&pages=166-175&publication_year=2004&author=Baxevanis%2CCN&author=Sotiropoulou%2CPA&author=Sotiriadou%2CNN&author=Papamichail%2CM?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10725753 generate?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20CD4%2B%20T%20lymphocytes%20from%20cancer%20patients%20are%20required%20for%20optimal%20induction%20of%20cytotoxic%20T%20cells%20against%20the%20autologous%20tumor&journal=J%20Immunol&volume=164&pages=3902-3912&publication_year=2000&author=Baxevanis%2CCN&author=Voutsas%2CIF&author=Tsitsilonis%2COE&author=Gritzapis%2CAD&author=Sotiriadou%2CR&author=Papamichail%2CM?
• How much does https://doi.org/10.1038%2F30996 net monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9624004 pull in monthly?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Help%20for%20cytotoxic-T-cell%20responses%20is%20mediated%20by%20CD40%20signalling&journal=Nature&doi=10.1038%2F30996&volume=393&pages=478-480&publication_year=1998&author=Bennett%2CSR&author=Carbone%2CFR&author=Karamalis%2CF&author=Flavell%2CRA&author=Miller%2CJF&author=Heath%2CWR have monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2766287 income
• Income figures for http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20an%20immunocytochemical%20assay%20for%20progesterone%20receptor%20with%20a%20biochemical%20method%20of%20measurement%20and%20immunocytochemical%20examination%20of%20the%20relationship%20between%20progesterone%20and%20estrogen%20receptors&journal=Cancer%20Res&volume=49&pages=5176-5179&publication_year=1989&author=Berger%2CU&author=Wilson%2CP&author=Thethi%2CS&author=McClelland%2CRA&author=Greene%2CGL&author=Coombes%2CRC
• How much does https://doi.org/10.1126%2Fscience.1072615 make?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12242444?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20role%20for%20CD40%20expression%20on%20CD8%2B%20T%20cells%20in%20the%20generation%20of%20CD8%2B%20T%20cell%20memory&journal=Science&doi=10.1126%2Fscience.1072615&volume=297&pages=2060-2063&publication_year=2002&author=Bourgeois%2CC&author=Rocha%2CB&author=Tanchot%2CC net monthly?
• Financial intake of https://doi.org/10.1517%2F14712598.4.2.181
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14998777?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Peptide-based%20vaccines%20for%20cancer%20immunotherapy&journal=Expert%20Opin%20Biol%20Ther&doi=10.1517%2F14712598.4.2.181&volume=4&pages=181-198&publication_year=2004&author=Brinkman%2CJA&author=Fausch%2CSC&author=Weber%2CJS&author=Kast%2CWM?
• How much does https://doi.org/10.1002%2Fpath.1679 pull in monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15586367 rake in every month?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Immunological%20mechanisms%20elicited%20at%20the%20tumour%20site%20by%20lymphocyte%20activation%20gene-3%20%28LAG-3%29%20versus%20IL-12%3A%20sharing%20a%20common%20Th1%20anti-tumor%20immune%20pathway&journal=J%20Pathol&doi=10.1002%2Fpath.1679&volume=205&pages=82-91&publication_year=2005&author=Carlo%2CED&author=Cappello%2CP&author=Sorrentino%2CC&author=D%E2%80%99Antuono%2CT&author=Pellicciotta%2CA&author=Giovarelli%2CM&author=Forni%2CG&author=Musiani%2CP&author=Triebel%2CF?
• Earnings of https://doi.org/10.1002%2F1521-4141%28200106%2931%3A6%3C1780%3A%3AAID-IMMU1780%3E3.0.CO%3B2-I
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11385623 each month?
• http://scholar.google.com/scholar_lookup?&title=Immunization%20with%20a%20tumor%20associated%20epitope%20plus%20a%20tumor-related%20or%20unrelated%20Th-helper%20peptide%2C%20elicits%20protective%20CTL%20immunity&journal=Eur%20J%20Immunol&doi=10.1002%2F1521-4141%28200106%2931%3A6%3C1780%3A%3AAID-IMMU1780%3E3.0.CO%3B2-I&volume=31&pages=1780-1789&publication_year=2001&author=Casares%2CN&author=Lasarte%2CJJ&author=Lopez-Diaz%20Cerio%2C&author=Sardoe%2CP&author=Ruiz%2CM&author=Melevo%2CI&author=Prieto%2CJ&author=Borras-Cuesta%2CF's financial summary
• Explore the financials of https://doi.org/10.1164%2Frccm.200504-588OC
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16151041 earning monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=CD4%2B%20CD25%2B%20regulatory%20T%20lymphocytes%20in%20malignant%20pleural%20effusion&journal=Am%20J%20Respir%20Crit%20Care%20Med&doi=10.1164%2Frccm.200504-588OC&volume=172&pages=1434-1439&publication_year=2005&author=Chen%2CYQ&author=Shi%2CHZ&author=Qin%2CXJ&author=Mo%2CWN&author=Liang%2CXD&author=Huang%2CZX&author=Yang%2CHB&author=Wu%2CC?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9066629 is on a monthly basis
• Income figures for http://scholar.google.com/scholar_lookup?&title=Existent%20proliferative%20responses%20of%20peripheral%20blood%20mononuclear%20cells%20from%20healthy%20donors%20and%20ovarian%20cancer%20patients%20to%20HER-2%20peptides&journal=Anticancer%20Res&volume=17&pages=45-53&publication_year=1997&author=Fisk%2CB&author=Hudson%2CJM&author=Kavanagh%2CJ&author=Wharton%2CJT&author=Murray%2CJL&author=Ioannides%2CCG&author=Kudelka%2CAP
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12438231
• How much does http://scholar.google.com/scholar_lookup?&title=Antigen-specific%20CD4%2B%20T%20cell%20help%20is%20required%20to%20activate%20a%20memory%20CD8%2B%20T%20cell%20to%20a%20fully%20functional%20tumor-killer%20cell&journal=Cancer%20Res&volume=62&pages=6438-6441&publication_year=2002&author=Gao%2CFG&author=Khammanivong%2CV&author=Liu%2CWJ&author=Leggatt%2CGR&author=Frazer%2CIH&author=Fernando%2CGJ net monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14740174's total income per month
• Get to know http://scholar.google.com/scholar_lookup?&title=Ii-Key%2FHER-2%2Fneu%20MHC%20class-II%20antigenic%20epitope%20vaccine%20peptide%20for%20breast%20cancer&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-003-0463-y&volume=53&pages=490-496&publication_year=2004&author=Gillogly%2CME&author=Kallinteris%2CNL&author=Xu%2CM&author=Gulfo%2CJV&author=Humphreys%2CRE&author=Murray%2CJL's earnings
• Profit of https://doi.org/10.1158%2F0008-5472.CAN-05-4018
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16707474 rake in every month?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Vaccination%20with%20human%20HER-2%2Fneu%28435-43%29%20cytotoxic%20T%20lymphocyte%20peptide%20induces%20effective%20antitumor%20immunity%20against%20HER-2%2Fneu%20expressing%20tumor%20cells%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-4018&volume=66&pages=5452-5460&publication_year=2006&author=Gritzapis%2CAD&author=Mahaira%2CLG&author=Perez%2CSA&author=Cacoullos%2CNT&author=Papamichail%2CM&author=Baxevanis%2CCN?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15164233
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Generation%20of%20human%20tumor-specific%20CTLs%20in%20HLA-A2.1-transgenic%20mice%20using%20unfractionated%20peptides%20from%20eluates%20of%20human%20primary%20breast%20and%20ovarian%20tumors&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-004-0541-9&volume=53&pages=1027-1040&publication_year=2004&author=Gritzapis%2CAD&author=Sotiriadou%2CNN&author=Papamichail%2CM&author=Baxevanis%2CCN produce monthly?
• https://doi.org/10.1016%2FS0264-410X%2800%2900067-0's revenue stream
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10781856?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Increasing%20the%20potency%20of%20MHC%20class%20II-presented%20epitopes%20by%20linkage%20to%20Ii-Key%20peptide&journal=Vaccine&doi=10.1016%2FS0264-410X%2800%2900067-0&volume=18&pages=2693-2697&publication_year=2000&author=Humphreys%2CRE&author=Adams%2CS&author=Koldzic%2CG&author=Nedelescu%2CB&author=Hofe%2CE&author=Xu%2CM earns monthly
• What's the income generated by https://doi.org/10.1084%2Fjem.191.4.625 each month?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10684854
• How much income does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20NY-ESO-1%20epitopes%20presented%20by%20human%20histocompatibility%20antigen%20%28HLA%29-DRB4%2A0101-103%20and%20recognized%20by%20CD4%28%2B%29%20T%20lymphocytes%20of%20patients%20with%20NY-ESO-1-expressing%20melanoma&journal=J%20Exp%20Med&doi=10.1084%2Fjem.191.4.625&volume=191&pages=625-630&publication_year=2000&author=Jager%2CE&author=Jager%2CD&author=Karbach%2CJ&author=Chen%2CYT&author=Ritter%2CG&author=Nagata%2CY&author=Gnjatic%2CS&author=Stockert%2CE&author=Arand%2CM&author=Old%2CLJ&author=Knuth%2CA have?
• How much money does https://doi.org/10.1016%2FS0264-410X%2803%2900493-6 generate?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14505892?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Ii-Key%2FMHC%20class%20II%20epitope%20hybrid%20peptide%20vaccines%20for%20HIV&journal=Vaccine&doi=10.1016%2FS0264-410X%2803%2900493-6&volume=21&pages=4128-4132&publication_year=2003&author=Kallinteris%2CNL&author=Lu%2CX&author=Wu%2CS&author=Hu%2CH&author=Li%2CY&author=Gulfo%2CJV&author=Humphreys%2CRE&author=Xu%2CM?
• What's the profit of https://doi.org/10.1097%2F01.cji.0000170362.45456.00?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16000953?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Enhanced%20CD4%2B%20T-cell%20response%20in%20DR4-transgenic%20mice%20to%20a%20hybrid%20peptide%20linking%20the%20Ii-Key%20segment%20of%20the%20invariant%20chain%20to%20the%20melanoma%20gp100%2848-8%29%20MHC%20class%20II%20epitope&journal=J%20Immunother&doi=10.1097%2F01.cji.0000170362.45456.00&volume=28&pages=352-358&publication_year=2005&author=Kallinteris%2CNL&author=Wu%2CS&author=Lu%2CX&author=Humphreys%2CRE&author=Hofe%2CE&author=Xu%2CM?
• How much income is https://doi.org/10.1128%2FJVI.78.9.4463-4477.2004 earning monthly?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15078927
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Comprehensive%20analysis%20of%20human%20immunodeficiency%20virus%20type%201-specific%20CD4%20responses%20reveals%20marked%20immunodominance%20of%20gag%20and%20nef%20and%20the%20presence%20of%20broadly%20recognized%20peptides&journal=J%20Virol&doi=10.1128%2FJVI.78.9.4463-4477.2004&volume=78&pages=4463-4477&publication_year=2004&author=Kaufmann%2CDE&author=Bailey%2CPM&author=Sidney%2CJ&author=Wagner%2CB&author=Norris%2CPJ&author=Johnston%2CMN&author=Cosimi%2CLA&author=Addo%2CMM&author=Lichterfeld%2CM&author=Altfeld%2CM&author=Frahm%2CN&author=Brander%2CC&author=Sette%2CA&author=Walker%2CBD&author=Rosenberg%2CES?
• What's the income generated by https://doi.org/10.1016%2FS0198-8859%2897%2900255-3 each month?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9544234?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20multi-epitope%20approach%20for%20immunotherapy%20for%20cancer%3A%20identification%20of%20several%20CTL%20epitopes%20from%20various%20tumor-associated%20antigens%20expressed%20on%20solid%20epithelial%20tumors&journal=Hum%20Immunol&doi=10.1016%2FS0198-8859%2897%2900255-3&volume=59&pages=1-14&publication_year=1998&author=Kawashima%2CI&author=Hudson%2CSJ&author=Tsai%2CV&author=Southwood%2CS&author=Takesako%2CK&author=Appella%2CE&author=Sette%2CA&author=Celis%2CE pull in?
• How much money does https://doi.org/10.1002%2Fijc.10713 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12402309 generate monthly?
• http://scholar.google.com/scholar_lookup?&title=Prostate%20stem%20cell%20antigen%3A%20Identification%20of%20immunogenic%20peptides%20and%20assessment%20of%20reactive%20CD8%2B%20T%20cells%20in%20prostate%20cancer%20patients&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10713&volume=102&pages=390-397&publication_year=2002&author=Kiessling%2CA&author=Schmitz%2CM&author=Stevanovic%2CS&author=Weigle%2CB&author=Holig%2CK&author=Fussel%2CM&author=Fussel%2CS&author=Meye%2CA&author=Wirth%2CMP&author=Rieber%2CEP's total income per month
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16010587
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Tumor%20antigen-specific%20T%20helper%20cells%20in%20cancer%20immunity%20and%20immunotherapy&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-004-0653-2&volume=54&pages=721-728&publication_year=2005&author=Knutson%2CKL&author=Disis%2CML?
• How much revenue does https://doi.org/10.1172%2FJCI11752 bring in?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11181647?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Immunization%20with%20a%20HER-2%2Fneu%20helper%20peptide%20vaccine%20generates%20HER-2%2Fneu%20CD8%20T-cell%20immunity%20in%20cancer%20patients&journal=J%20Clin%20Invest&doi=10.1172%2FJCI11752&volume=107&pages=477-484&publication_year=2001&author=Knutson%2CKL&author=Schiffman%2CK&author=Disis%2CML
• How much income does https://doi.org/10.1016%2Fj.immuni.2004.12.005 have?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15664164
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Cooperation%20of%20human%20tumor-reactive%20CD4%2B%20and%20CD8%2B%20T%20cells%20after%20redirection%20of%20their%20specificity%20by%20a%20high-affinity%20p53A2.1-specific%20TCR&journal=Immunity&doi=10.1016%2Fj.immuni.2004.12.005&volume=22&pages=117-129&publication_year=2005&author=Kuball%2CJ&author=Schmitz%2CFW&author=Voss%2CRH&author=Ferreira%2CEA&author=Engel%2CR&author=Guillaume%2CP&author=Strand%2CS&author=Romero%2CP&author=Huber%2CC&author=Sherman%2CLA&author=Theobald%2CM?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12168827?
• How much does http://scholar.google.com/scholar_lookup?&title=Helper%20peptide%20G89%20%28HER-2%3A777-89%29%20and%20G89-activated%20cells%20regulate%20the%20survival%20of%20effectors%20induced%20by%20the%20CTL%20epitope%20E75%20%28HER-2%2C%20369-77%29.%20Correlation%20with%20the%20IFN-gamma%3A%20IL-10%20balance&journal=Anticancer%20Res&volume=22&pages=1481-1490&publication_year=2002&author=Lee%2CTV&author=Johnston%2CDA&author=Thomakos%2CN&author=Honda%2CT&author=Efferson%2CCL&author=Ioannides%2CCG generate monthly?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2373862
• Income figures for http://scholar.google.com/scholar_lookup?&title=Role%20of%20recurrent%20hydrophobic%20residues%20in%20catalysis%20of%20helix%20formation%20by%20T%20cell-presented%20peptides%20in%20the%20presence%20of%20lipid%20vesicles&journal=J%20Immunol&volume=145&pages=899-904&publication_year=1990&author=Lu%2CS&author=Reyes%2CVE&author=Lew%2CRA&author=Anderson%2CJ&author=Mole%2CJ&author=Humphreys%2CRE&author=Ciardelli%2CT
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11086036?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20CD4%2B%20T%20cells%20have%20a%20major%20%E2%80%9Cpost-licensing-role%20in%20CTL%20mediated%20anti-tumor%20immunity&journal=J%20Immunol&volume=165&pages=6047-6055&publication_year=2000&author=Marzo%2CAL&author=Kinnear%2CBF&author=Lake%2CRA&author=Frelinger%2CJJ&author=Collins%2CEJ&author=Robinson%2CBW&author=Scott%2CB
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15980996 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20the%20CD107%20cytotoxicity%20assay%20for%20the%20detection%20of%20cytolytic%20CD8%2B%20cells%20recognizing%20HER2%2Fneu%20vaccine%20peptides&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-005-0988-1&volume=92&pages=85-93&publication_year=2005&author=Mittendorf%2CEA&author=Storrer%2CCE&author=Shriver%2CCD&author=Ponniah%2CS&author=Peoples%2CGE make?
• What's the income of https://doi.org/10.1084%2Fjem.20032118?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15173207's total income per month
• http://scholar.google.com/scholar_lookup?&title=Expansion%20of%20melanoma-specific%20cytolytic%20CD8%2B%20T%20cell%20precursors%20in%20patients%20with%20metastatic%20melanoma%20vaccinated%20with%20CD34%2B%20progenitor-derived%20dendritic%20cells&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20032118&volume=199&pages=1503-1511&publication_year=2004&author=Paczesny%2CS&author=Banchereau%2CJ&author=Wittkowski%2CKM&author=Saracino%2CG&author=Fay%2CJ&author=Palucka%2CAK income
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11807625
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=HER-2%2Fneu-derived%20peptide%20884-99%20is%20expressed%20by%20human%20breast%2C%20colorectal%20and%20pancreatic%20adenocarcinomas%20and%20is%20recognized%20by%20in-vitro-induced%20specific%20CD4%28%2B%29%20T%20cell%20clones&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620100225&volume=50&pages=615-624&publication_year=2002&author=Perez%2CSA&author=Sotiropoulou%2CPA&author=Sotiriadou%2CNN&author=Mamalaki%2CA&author=Gritzapis%2CAD&author=Echner%2CH&author=Voelter%2CW&author=Pawelec%2CG&author=Papamichail%2CM&author=Baxevanis%2CCN?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14555509
• How much does http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20pre-existent%20immunity%20in%20patients%20with%20primary%20breast%20cancer%3A%20molecular%20and%20cellular%20assays%20to%20quantify%20antigen-specific%20T%20lymphocytes%20in%20peripheral%20blood%20mononuclear%20cells&journal=Clin%20Cancer%20Res&volume=9&pages=4376-4386&publication_year=2003&author=Rentzsch%2CC&author=Kayser%2CS&author=Stumm%2CS&author=Watermann%2CI&author=Walter%2CS&author=Stevanovic%2CS&author=Wallwiener%2CD&author=Guckel%2CB rake in every month?
• How much does https://doi.org/10.1038%2F30989 rake in every month?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9624003 gross monthly?
• http://scholar.google.com/scholar_lookup?&title=A%20conditioned%20dendritic%20cell%20can%20be%20a%20temporal%20bridge%20between%20a%20CD4%2B%20T-helper%20and%20a%20T-killer%20cell&journal=Nature&doi=10.1038%2F30989&volume=393&pages=474-478&publication_year=1998&author=Ridge%2CJP&author=Di%20Rosa%2CF&author=Matzinger%2CP's financial summary
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10395702?
• How much does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20new%20HER2%2Fneu-derived%20peptide%20epitopes%20that%20can%20elicit%20specific%20CTL%20against%20autologous%20and%20allogeneic%20carcinomas%20and%20melanomas&journal=J%20Immunol&volume=163&pages=1037-1044&publication_year=1999&author=Rongcun%2CY&author=Salazar-Onfray%2CF&author=Charo%2CJ&author=Malmberg%2CKJ&author=Evrin%2CK&author=Maes%2CH&author=Kono%2CK&author=Hising%2CC&author=Petersson%2CM&author=Larsson%2CO&author=Lan%2CL&author=Appella%2CE&author=Sette%2CA&author=Celis%2CE&author=Kiessling%2CR pull in?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14654536?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Immunization%20of%20cancer%20patients%20with%20HER-2%2Fneu-derived%20peptides%20demonstrating%20high-affinity%20binding%20to%20multiple%20class%20II%20alleles&journal=Clin%20Cancer%20Res&volume=9&pages=5559-5565&publication_year=2003&author=Salazar%2CLG&author=Fikes%2CJ&author=Southwood%2CS&author=Ishioka%2CG&author=Knutson%2CKL&author=Gooley%2CTA&author=Schiffman%2CK&author=Disis%2CML?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10640737?
• What's http://scholar.google.com/scholar_lookup?&title=Retrovirally%20transduced%20mouse%20dendritic%20cells%20require%20CD4%2B%20T%20cell%20help%20to%20elicit%20antitumor%20immunity%3A%20implications%20for%20the%20clinical%20use%20of%20dendritic%20cells&journal=J%20Immunol&volume=164&pages=1243-1250&publication_year=2000&author=Schnell%2CS&author=Young%2CJW&author=Houghton%2CAN&author=Sadelain%2CM's gross income?
• How much money does https://doi.org/10.1038%2F31002 make?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9624005 making per month?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=T-cell%20help%20for%20cytotoxic%20T%20lymphocytes%20is%20mediated%20by%20CD40-CD40L%20interactions&journal=Nature&doi=10.1038%2F31002&volume=393&pages=480-483&publication_year=1998&author=Schoenberger%2CSP&author=Toes%2CRE&author=Voort%2CEI&author=Offringa%2CR&author=Melief%2CCJ
• Explore the financials of https://doi.org/10.1054%2Fbjoc.2001.2089
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11720440
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Peptide%20HER2%28776-88%29%20represents%20a%20naturally%20processed%20broad%20MHC%20class%20II-restricted%20T%20cell%20epitope&journal=Br%20J%20Cancer&doi=10.1054%2Fbjoc.2001.2089&volume=85&pages=1527-1534&publication_year=2001&author=Sotiriadou%2CR&author=Perez%2CSA&author=Gritzapis%2CAD&author=Sotiropoulou%2CPA&author=Echner%2CH&author=Heinzel%2CS&author=Mamalaki%2CA&author=Pawelec%2CG&author=Voelter%2CW&author=Baxevanis%2CCN&author=Papamichail%2CM is on a monthly basis
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=13680193's financial summary
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Natural%20CD8%2B%20T-cell%20responses%20against%20MHC%20class%20I%20epitopes%20of%20the%20HER-2%2F%20neu%20oncoprotein%20in%20patients%20with%20epithelial%20tumors&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-003-0420-9&volume=52&pages=771-779&publication_year=2003&author=Sotiropoulou%2CPA&author=Perez%2CSA&author=Voelter%2CV&author=Echner%2CH&author=Missitzis%2CI&author=Tsavaris%2CNB&author=Papamichail%2CM&author=Baxevanis%2CCN produce monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9717833 generate?
• http://scholar.google.com/scholar_lookup?&title=Proliferative%20and%20cytokine%20responses%20to%20class%20II%20HER-2%2Fneu-associated%20peptides%20in%20breast%20cancer%20patients&journal=Clin%20Cancer%20Res&volume=4&pages=2015-2024&publication_year=1998&author=Tuttle%2CTM&author=Anderson%2CBW&author=Thompson%2CWE&author=Lee%2CJE&author=Sahin%2CA&author=Smith%2CTL&author=Grabstein%2CKH&author=Wharton%2CJT&author=Ioannides%2CCG&author=Murray%2CJL's revenue stream
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10569202?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Human%20tumor%20antigens%3A%20implications%20for%20cancer%20vaccine%20development&journal=J%20Mol%20Med&doi=10.1007%2Fs001099900042&volume=77&pages=640-655&publication_year=1999&author=Wang%2CRF earns monthly
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14629132 net monthly?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Essential%20roles%20of%20tumor-derived%20helper%20T%20cell%20epitopes%20for%20an%20effective%20peptide-based%20tumor%20vaccine&journal=Cancer%20Immunity&volume=3&pages=16-29&publication_year=2003&author=Wang%2CL&author=Miyahara%2CY&author=Kato%2CT&author=Wang%2CL&author=Aota%2CT&author=Kuribayashi%2CK&author=Shiku%2CH?
• Get to know https://doi.org/10.1111%2Fj.1600-065X.1999.tb01331.x's earnings
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10566144 pull in monthly?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Human%20tumor%20antigens%20for%20cancer%20vaccine%20development&journal=Immunol%20Rev&doi=10.1111%2Fj.1600-065X.1999.tb01331.x&volume=170&pages=85-100&publication_year=1999&author=Wang%2CRF&author=Rosenberg%2CSA?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12576425?
• Get to know http://scholar.google.com/scholar_lookup?&title=Increase%20of%20regulatory%20T%20cells%20in%20the%20peripheral%20blood%20of%20cancer%20patients&journal=Clin%20Cancer%20Res&volume=9&pages=606-612&publication_year=2003&author=Wolf%2CAM&author=Wolf%2CD&author=Steurer%2CM&author=Gastl%2CG&author=Gunsilius%2CE&author=Grubeck-Loebenstein%2CB's earnings
• How much revenue does https://doi.org/10.1016%2F0161-5890%2894%2990146-5 generate?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8035834 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Cathepsin%20B%20cleavage%20and%20release%20of%20invariant%20chain%20from%20MHC%20class%20II%20molecules%20follow%20a%20staged%20pattern&journal=Mol%20Immunol&doi=10.1016%2F0161-5890%2894%2990146-5&volume=31&pages=723-731&publication_year=1994&author=Xu%2CM&author=Capraro%2CGA&author=Daibata%2CM&author=Reyes%2CVE&author=Humphreys%2CRE gross monthly?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10514908 earns monthly
• Income figures for http://scholar.google.com/scholar_lookup?&title=Studies%20on%20activities%20of%20invariant%20chain%20peptides%20on%20releasing%20or%20exchanging%20of%20antigenic%20peptides%20at%20human%20leukocyte%20antigen-DR1&journal=Arzneimittelforschung&volume=49&pages=791-799&publication_year=1999&author=Xu%2CM&author=Jackson%2CR&author=Adams%2CS&author=Humphreys%2CRE
• Discover the revenue of https://doi.org/10.1016%2Fj.vaccine.2003.12.036
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15519713 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=On%20the%20road%20to%20a%20tumor%20cell%20vaccine%3A%2020%C2%A0years%20of%20cellular%20immunotherapy&journal=Vaccine&doi=10.1016%2Fj.vaccine.2003.12.036&volume=23&pages=97-113&publication_year=2004&author=Yannelli%2CJR&author=Wroblewski%2CJM net monthly?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9809997
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Immunization%20with%20a%20peptide%20epitope%20%28p369-77%29%20from%20HER-2%2Fneu%20leads%20to%20peptide-specific%20cytotoxic%20T%20lymphocytes%20that%20fail%20to%20recognize%20HER-2%2Fneu%2B%20tumors&journal=Cancer%20Res&volume=58&pages=4902-4908&publication_year=1998&author=Zaks%2CTZ&author=Rosenberg%2CSA?
• What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0213-z?format=refman&flavour=references?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nectaria%20N.%20Sotiriadou generate monthly?
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nectaria%20N.%20Sotiriadou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nikoletta%20L.%20Kallinteris?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nikoletta%20L.%20Kallinteris%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Angelos%20D.%20Gritzapis
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Angelos%20D.%20Gritzapis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ioannis%20F.%20Voutsas generate monthly?
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ioannis%20F.%20Voutsas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Papamichail make?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Papamichail%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eric%20von%20Hofe?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eric%20von%20Hofe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20E.%20Humphreys generate?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20E.%20Humphreys%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Theodoros%20Pavlis making per month?
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Theodoros%20Pavlis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sonia%20A.%20Perez?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sonia%20A.%20Perez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Constantin%20N.%20Baxevanis's earnings
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Constantin%20N.%20Baxevanis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=Ii-Key%2FHER-2%2Fneu%28776-90%29%20hybrid%20peptides%20induce%20more%20effective%20immunological%20responses%20over%20the%20native%20peptide%20in%20lymphocyte%20cultures%20from%20patients%20with%20HER-2%2Fneu%2B%20tumors&author=Nectaria%20N.%20Sotiriadou%20et%20al&contentID=10.1007%2Fs00262-006-0213-z©right=Springer-Verlag&publication=0340-7004&publicationDate=2006-09-08&publisherName=SpringerNature&orderBeanReset=true?
• Find out how much https://citation-needed.springer.com/v2/references/10.1007/s00262-006-0213-z?format=refman&flavour=citation earns monthly
• How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral bring in?
• What's the monthly income of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• Get to know https://www.springernature.com/gp/products's earnings
• Earnings of https://www.springernature.com/gp/librarians
• Discover the revenue of https://www.springernature.com/gp/societies
• What's the financial gain of https://www.springernature.com/gp/partners?
• How much revenue does https://www.springer.com/ produce monthly?
• What's the financial outcome of https://www.nature.com/?
• What's the income generated by https://www.biomedcentral.com/ each month?
• Monthly income for https://www.palgrave.com/
• How much money does https://www.apress.com/ make?
• How much money does https://www.springernature.com/gp/legal/ccpa make?
• What's the monthly money flow for https://www.springernature.com/gp/info/accessibility?
• How much does https://support.springernature.com/en/support/home pull in?
• How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations produce monthly?
• Learn how profitable https://www.springernature.com/ is on a monthly basis

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref